Vortioxetine for Cognitive Function in ALK-positive NSCLC Treated With Lorlatinib

Conditions

• Advanced ALK/ROS1-positive NSCLC
• Carcinoma, Non-Small-Cell Lung (NSCLC)
• Lung Adenocarcinoma
• ALK-positive Non-small Cell Lung Cancer (NSCLC)
• Cognitive Dysfunction
• Depression

Sponsor

Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo